Détail du document
Identifiant

oai:pubmedcentral.nih.gov:1125...

Sujet
Review
Auteur
Ma, Xiangyu Guo, Jiamin Tian, Mengyao Fu, Yaoyang Jiang, Pei Zhang, Yuan Chai, Renjie
Langue
en
Editeur

Springer Nature Singapore

Catégorie

Neuroscience Bulletin

Année

2023

Date de référencement

24/07/2024

Métrique

Résumé

Hearing loss and deafness, as a worldwide disability disease, have been troubling human beings.

However, the auditory organ of the inner ear is highly heterogeneous and has a very limited number of cells, which are largely uncharacterized in depth.

Recently, with the development and utilization of single-cell RNA sequencing (scRNA-seq), researchers have been able to unveil the complex and sophisticated biological mechanisms of various types of cells in the auditory organ at the single-cell level and address the challenges of cellular heterogeneity that are not resolved through by conventional bulk RNA sequencing (bulk RNA-seq).

Herein, we reviewed the application of scRNA-seq technology in auditory research, with the aim of providing a reference for the development of auditory organs, the pathogenesis of hearing loss, and regenerative therapy.

Prospects about spatial transcriptomic scRNA-seq, single-cell based genome, and Live-seq technology will also be discussed.

Ma, Xiangyu,Guo, Jiamin,Tian, Mengyao,Fu, Yaoyang,Jiang, Pei,Zhang, Yuan,Chai, Renjie, 2023, Advance and Application of Single-cell Transcriptomics in Auditory Research, Springer Nature Singapore

Partager

Source

Articles recommandés par ES/IODE IA

MELAS: Phenotype Classification into Classic-versus-Atypical Presentations
presentations mitochondrial strokelike patients variability phenotype clinical melas
Protocol for the promoting resilience in stress management (PRISM) intervention: a multi-site randomized controlled trial for adolescents and young adults with advanced cancer
cancer quality of life anxiety depression hope coping skills communication intervention randomized ayas outcomes resilience care trial cancer prism-ac advanced